Features
Screener
Pricing
Resources
About
en
Features
Screener
Pricing
Resources
About
Language
en
Login
Start for free
DISCOVER
Screener
Stocks
ETF
Crypto
SCPI
Trending
Comparator
Calendar
Charting
Super investors
SOCIAL
Community
Public portfolios
/
Image Modal
Image Modal Description
Merck & Co., Inc.
MRK
-
US58933Y1055
Compare
Last update : Aug 21, 2026 at 22:45
General
Scores
Financials
Ratios
Valuation
Dividend
Exposure
Analysts
Insider
Merck & Co., Inc. (MRK) Dividend, Growth and Profitability Scores - Invvest
Dividend
Last update : Jul 31, 2026
11
LqvoqcVS
Metrics
Value
Rating
Payout ratio
24
C2xr8
1YVTC
Free cash flow payout ratio
25
6SKPN
guu77
3Y Earnings growth
28
LbahC
dtKBb
Dividend streak
26
42vno
fwQNQ
Dividend growth streak
16
rmBda
vh1O1
5Y Dividend growth
32
3QjFX
oUpOw
15Y Dividend cut
10
gEjFt
yDEnp
15Y Dividend interruption
91
GjuH8
8xLfR
Return on equity
31
azsxQ
M1lq4
Net debt / EBITDA
5
iZjQi
juiYG
Interest coverage
1
Fy18d
Bz1GC
Growth
Last update : Jul 30, 2026
18
cnFHT
Metrics
Value
Rating
Revenue growth
24
faXko
l7Hko
5Y Revenue growth
87
uMfOy
3MbkO
EBITDA growth
11
glq1K
Financial Strength
Last update : Jul 30, 2026
12
Dma
Metrics
Value
Rating
Interest coverage
1
cBfY4
SYGgg
Quick ratio
57
CjQAs
EcrZ0
Debt / Assets
56
pDv6o
JkTNp
Profitability
Last update : Jul 30, 2026
17
bhbCDGdb
Metrics
Value
Rating
Gross margin
90
s9MjX
pQ6yE
Operating margin
12
BIgqJ
YN7Wz
Net margin
10
A1Rzd
L79SR
Momentum
Last update : Aug 16, 2026
19
sMe
Metrics
ESG
Last update : Dec 31, 2025
6
vsZrw85
Metrics
Value
Rating
Environmental
86.07
AAA
Social
72.61
AA
Governance
16.25
Piotroski F
Last update : Aug 4, 2026
5
Unlock this feature
0
3
6
9
Altman Z
Last update : Aug 4, 2026
5
Unlock this feature
0 and -
1.8
3
4.5 and +
ZS7Yr
5Y EBITDA growth
30
Oq674
SSG15
Operating income growth
15
fiMu9
07Trg
5Y Operating income growth
26
qjS9J
hb68K
Net income growth
60
k0lZC
1QTjk
Free cash flow growth
40
Vb1AY
4oiKP
5Y Free cash flow growth
21
o4ZUt
3MiWb
Operating cash flow growth
66
Tc3pZ
rpZP6
5Y Operating cash flow growth
20
vyxfX
P5GHl
Capex growth
81
kCM1s
ZvRXe
Debt / Equity
77
N05ZN
atJka
Net debt / EBITDA
15
xslHq
ZLA7n
Cash / Debt
100
xTqrl
BcrQO
Altman Z Score
80
qGjJo
1QT4y
Piotroski F Score
60
E8raI
Srkxq
Capex coverage ratio
84
0VuMk
K9ose
Free cash flow margin
89
IobEE
Thgs9
Return on invested capital
96
5DWwy
TfGZA
Return on equity
23
Adxur
9JoXy
Return on assets
1
qqC0K
fZiCl
Capex / Revenue
36
o96RS
fTbrI
Profitable years 5Y
91
HXYhc
rHQ1n
Value
Rating
SMA 50 vs Price
34
LhtLh
zLbhz
SMA 200 vs Price
1
lZDNF
9qfjT
SMA 50 vs SMA 200
97
38YSR
GcazN
1M Decile rank
78
ngAl8
iKVUe
6M Decile rank
95
WDwY0
5r0NE
1Y Decile rank
56
FBeuh
CxUeX
B
